Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

How Companies in Kenya Can Source Pharma Products & CDMO Services (2026 Guide)

Kenya • Source Pharma Products & CDMO Services

Mitul Agarwal
Written by Mitul Agarwal · B.Pharm, MBA
Founder & Head of Business Development · 25+ years in international pharmaceutical BD&L
Published 4 December 2025 · Reviewed and updated 21 October 2026
How Companies in Kenya Can Source Pharma Products & CDMO Services (2026 Guide)

Introduction

Kenya is East Africa's main commercial and logistics hub. Its market serves a growing population with rising rates of chronic disease, alongside continuing demand for anti-infectives, antimalarials and HIV and TB treatments. Through the Port of Mombasa, Kenya also supplies neighbouring markets such as Uganda, Rwanda and South Sudan.

The Pharmacy and Poisons Board (PPB) regulates health products, and the Kenya Medical Supplies Authority (KEMSA) is the main public-sector buyer. This guide covers where supply comes from, what Kenyan buyers source, how to qualify suppliers, the documents and permits you need, and practical fixes for common problems.

Where supply comes from

Kenyan importers, distributors, hospitals and local manufacturers usually draw on several supply bases.

Main supply bases

  • India and China: the main sources of generic APIs, and India supplies a large share of Kenya's imported finished generics.
  • Europe (EU-GMP): sterile injectables, specialty hospital products, biologics and products backed by stringent-regulator approvals.
  • United States: specialty medicines, biologics and some diagnostics.
  • Kenya and the region: Kenya has one of East Africa's larger local manufacturing bases for tablets, liquids and topicals. Egypt and South Africa supply selected generics, and East African Community (EAC) partner states trade within the region.

What decides the choice

Buyers weigh inspection history, dossier readiness for PPB, the ability to meet KEMSA or private tender volumes, and landed cost after freight and duties. For donor-funded products, WHO prequalification often decides eligibility.

Pharma categories supply

CategoryTypical productsNotes for buyers
Anti-infectivesOral and injectable antibiotics, antifungalsHigh volume, strong price competition
Antimalarials, HIV and TBArtemisinin combinations, ARVs, TB regimensOften donor-funded; WHO prequalification typically required
Chronic disease medicinesAntihypertensives, antidiabetics, insulin, statinsGrowing demand in private and county facilities
Sterile injectables and IV fluidsSmall-volume parenterals, infusions, oncology vialsNeeds inspected sterile sites and reliable cold chain
APIs and excipientsBulk APIs for local formulationMostly from Asia; check DMF or CEP status
OTC, nutraceuticals and devicesVitamins, supplements, syringes, diagnosticsPPB regulates many of these as health products

CDMO and contract services

Kenyan brand owners use contract manufacturers for private-label generics and OTC lines, while foreign companies look for local partners for packaging, distribution and, increasingly, local production for the EAC market.

How to source pharma products

  1. Write a clear brief. Molecule, strength, dosage form, pack size, annual volume, channel (private, KEMSA, county or donor) and whether you need a registered product.
  2. Shortlist qualified sites. Look for WHO prequalification, EU-GMP, US FDA or PIC/S inspection history. PPB may inspect the site or rely on recognised inspections.
  3. Verify documents. Check the GMP certificate with the issuing authority, and request a WHO-format COPP, recent CoAs and Zone IVb stability data (30°C/75% RH), which the EAC expects.
  4. Appoint a local technical representative. Foreign applicants need a Kenyan local technical representative (LTR) to handle registration, safety reporting and recalls.
  5. Review the dossier. PPB works in the CTD format. Ask for a gap analysis against PPB and EAC guidelines before you sign.
  6. Agree commercial terms and pilot. Settle MOQ, Incoterms, payment terms and a quality agreement, then test the chain with a small first order.

PharmaTradz lets buyers compare offers from GMP-certified manufacturers and CDMOs across Asia, Europe, the Americas and Africa. Post your need as a request for quotation, and check each offer with our guide on how to verify a pharmaceutical supplier.

Required documents for import

Regulatory and quality documents

  • PPB registration (marketing authorisation) for the product
  • A valid PPB licence for the importing premises
  • PPB import permit for the consignment, applied for online and linked to the Kenya National Electronic Single Window (KenTrade)
  • GMP certificate for the manufacturing site
  • Batch Certificate of Analysis
  • Certificate of Pharmaceutical Product (COPP) where requested

Commercial and customs documents

  • Commercial invoice and packing list
  • Bill of lading or air waybill
  • Certificate of origin, including EAC or COMESA certificates where preferential duty applies
  • Temperature records for cold-chain cargo
  • Customs entry lodged with the Kenya Revenue Authority (KRA) through a licensed clearing agent

PPB inspectors check consignments at ports of entry. Products, batch numbers and quantities must match the permit exactly.

Logistics and shipping

Main entry points

  • Sea: the Port of Mombasa handles most cargo. Containers can move inland on the Standard Gauge Railway to the Inland Container Depot in Nairobi. Lamu Port is a newer alternative.
  • Air: Jomo Kenyatta International Airport (JKIA) in Nairobi is the main air cargo hub, with well-developed cold storage. Moi International in Mombasa is a secondary option.

Indicative transit times

OriginSea freight to MombasaAir freight to Nairobi
AsiaTypically 2–4 weeks port to portTypically 2–5 days
EuropeTypically 3–5 weeks, longer if routed around the CapeTypically 2–4 days

Add time for clearance and inland transport, especially for cargo going on to Uganda or Rwanda.

Cold chain and Incoterms

Vaccines, insulin and biologics usually come by air into JKIA. Use validated packaging, temperature loggers and GDP-compliant forwarders, and agree who carries excursion risk at each handover. For support, see our cold chain pharma logistics service.

Most buyers buy on FCA, CFR or CIF, and choose DAP or DDP only when the supplier has a capable Kenyan clearing partner.

Common challenges and practical solutions

ChallengePractical solution
Slow PPB registrationPrioritise WHO-prequalified or stringent-regulator approved products for reliance routes, and file a complete CTD with Zone IVb data.
Weak local representationChoose an LTR with regulatory staff, a clear pharmacovigilance process and a track record with PPB.
Falsified and substandard productsBuy only registered products from licensed premises and check registration status on PPB records.
Port and inland delaysLodge documents early, use an experienced clearing agent and consider air freight for urgent items.
Tender payment cyclesPlan working capital and agree payment terms with suppliers that match KEMSA and county timelines.
Single-source riskQualify a second source for critical medicines, ideally from a different region.

Conclusion

Kenyan buyers do best when they combine a strong local representative, PPB-ready dossiers and a clear view of the KEMSA, county and private channels. Using EAC joint assessment and reliance routes can save time, and a well-run cold chain through JKIA or Mombasa protects product quality.

PharmaTradz works with GMP-certified manufacturers and CDMOs across Asia, Europe, the Americas and Africa and can help you compare suppliers for Kenya. For more context, visit our Kenya country hub.

Frequently Asked Questions

Does a foreign manufacturer need a local representative in Kenya?

Yes. PPB requires a Kenyan local technical representative to handle registration, safety reporting and recalls.

Do I need a PPB import permit for every shipment?

Yes. Each consignment needs a permit, and the goods must match it when PPB inspectors check them at the port of entry.

Which stability zone applies to Kenya?

Zone IVb (30°C/75% RH), in line with EAC requirements.

Can an EAC joint assessment speed up registration in Kenya?

It can. A positive joint assessment supports registration in several EAC states, though each still issues its own approval.

How long is a PPB marketing authorisation valid?

Five years under the 2022 registration rules, after which it must be renewed.

How does KEMSA buy medicines?

Through tenders for public facilities. Bidders typically need PPB-registered products and must meet the tender's quality and delivery terms.

Source Pharma Products & CDMO Services — other markets

Disclaimer: The information presented in this article is for informational and educational purposes only. While every effort has been made to ensure data accuracy and reliability, readers are advised to independently verify all figures, regulations, and market insights before making any business or investment decisions.

Planning to register or source in Kenya?

Tell us the molecule, dosage form and target market. We will come back on the regulatory pathway and whether the project is realistic before you commit anything.

Submit a Requirement Ask a question
Are you a manufacturer rather than a buyer?
If you already hold WHO-GMP, EU-GMP, USFDA or PIC/S approval, you are closer to supplying Kenya than you probably think.
Supply LATAM & Caribbean
Don't take our word for it
Kenya's regulator publishes a register of authorised products. Look up any supplier's claims yourself — including ours.
Verify a supplier

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us